Effect of adherence on daytime sleepiness, fatigue, depression and sleep quality in the obstructive sleep apnea/hypopnea syndrome patients undertaking nasal continuous positive airway pressure therapy

• Published in: Patient preference and adherence 2017-01, Vol.11, p.769-779
• Main Authors: Wang, Yeying, Ai, Li, Luo, Jiahong, Li, Ran, Chai, Yanlin, He, Xiaojie, Cao, Yu, Li, Yongxia
• Format: Article
• Language: English
• Subjects: Analysis; Care and treatment; Continuous positive airway pressure; daytime sleepiness; depression; Depression (Mood disorder); Fatigue; nCPAP; Original Research; OSAS; Patient compliance; Sleep; Sleep apnea; sleep quality
• ISSN: 1177-889X; 1177-889X
• DOI: 10.2147/PPA.S128217

The aims of this study were to describe changes in day- and nighttime symptoms and the adherence to nasal continuous positive airway pressure (nCPAP) during the first 3-month nCPAP therapy among newly diagnosed patients with obstructive sleep apnea/hypopnea syndrome (OSAS) and to identify the effect of adherence on the changes in day- and nighttime symptoms during the first 3 months. Newly diagnosed OSAS patients were consecutively recruited from March to August 2013. Baseline clinical information and measures of the Epworth Sleepiness Scale (ESS), Fatigue Severity Scale (FSS), Zung's Self-Rating Depression Scale (SDS) and the Pittsburgh Sleep Quality Index (PSQI) at baseline and the end of 3rd, 6th, 9th and 12th week of therapy were collected. Twelve weeks' adherence was calculated as the average of each 3-week period. Mixed model was used to explore the effect of adherence to nCPAP therapy on ESS, FSS, SDS and PSQI in each 3-week phase. Seventy-six patients completed the 12-week follow-up. The mixed-effects models showed that under the control of therapy phase adherence in the range of